Postexposure prophylaxis after sexual exposure to HIV

被引:26
作者
Roland, Michelle E. [1 ]
机构
[1] Univ Calif San Francisco, Posit Hlth AIDS Program, San Francisco Gen Hosp, San Francisco, CA 94110 USA
关键词
antiretroviral drugs; HIV; postexposure prophylaxis; prevention;
D O I
10.1097/QCO.0b013e328012c5e0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of review HIV postexposure prophylaxis is often recommended following potential sexual exposure to HIV. Recent data address the effectiveness of postexposure prophylaxis and prevention counseling, cost-effectiveness, antiretroviral options, challenges with nonoccupational postexposure prophylaxis among adolescents and children and following sexual assault in high HIV prevalence areas, and a successful program in Amsterdam. Recent findings Postexposure prophylaxis is not completely protective. Seroconversion may result from antiretroviral failure or from ongoing exposures. Postexposure prophylaxis associated risk reduction counseling results in reductions in subsequent risk behavior. Programs that target outreach and limit prescriptions to those with exposure sources who are at risk of being HIV infected are cost-effective. Less restrictive guidelines result in more prescriptions for low-risk exposures; this practice is not cost-effective. The ideal antiretrovirals for postexposure prophylaxis use have not been established. Tenofovir has several attractive properties. Developing systems to support the effective delivery of postexposure prophylaxis among children and adolescents and following sexual assault in high HIV prevalence, resource limited settings is challenging. Summary Numerous national and international guidelines recommend postexposure prophylaxis following potential sexual exposure to HIV. Maximizing adherence and minimizing subsequent HIV exposures will be critical to enhancing the effectiveness of this HIV prevention intervention.
引用
收藏
页码:39 / 46
页数:8
相关论文
共 62 条
  • [1] Almeda J, 2004, Euro Surveill, V9, P35
  • [2] ALMEDA J, 2004, 15 INT AIDS C 11 16
  • [3] ALMEDA J, 2002, PRACTICE GUIDELINES, P129
  • [4] *AUSTR NAT COUNC A, 2001, GUID MAN POST PROPH
  • [5] Two drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIV
    Bassett, IV
    Freedberg, KA
    Walensky, RP
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (03) : 395 - 401
  • [6] *BOTSW MIN HLTH, 2002, REV GUID US MON ANT
  • [7] Prescribing practices in a population-based HIV postexposure prophylaxis program
    Braitstein, P
    Chan, K
    Beardsell, A
    McLeod, A
    Montaner, JSG
    O'Shaughnessy, MV
    Hogg, RS
    [J]. AIDS, 2002, 16 (07) : 1067 - 1070
  • [8] *BROWN U AIDS PROG, 2002, NON HIV PEP TASK FOR
  • [9] Nucleic acid amplification testing for diagnosis of acute HIV infection: has the time come?
    Busch, MP
    Hecht, FA
    [J]. AIDS, 2005, 19 (12) : 1317 - 1319
  • [10] *CAL TASK FORC NON, 2004, OFF HIV POST PROPH P